CRB-601-01

· Corbus Pharmaceuticals Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CRB-601-01, covering 2025-06-03 to 2025-06-03. Get the full timeline:

Most recent: Clinical Trial Update: First-in-human Study of CRB-601-01 to Treat Patients With Advanced Solid Tumor. [Phase 1, Phase 2]